Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 64 results for diabetic foot

  1. MolecuLight i:X for wound imaging (MIB212)

    NICE has developed a medtech innovation briefing (MIB) on MolecuLight i:X for wound imaging .

    Medtech innovation briefing
    Published
    18 June 2020

  2. Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (HTG175)

    Evidence-based recommendations on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy. This involves removing parts of the pancreas (islet cells) after the pancreas has been removed and inserting them into the liver to restart insulin production.

    HealthTech guidance
    Published
    24 September 2008
    View recommendations

    Sections for HTG175

  3. Cost saving guidance

    savings: £1,800 Medical technologies guidance on UrgoStart for treating diabetic foot ulcers and leg ulcers (MTG42) Potential savings...

  4. Referral criteria for the foot protection service and the multidisciplinary foot care service:- When and with what criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?

    NG19/2 Question Referral criteria for the foot protection service and the multidisciplinary foot care service:- When and...

    Research recommendation
    Published
    12 October 2015

  5. The Debrisoft monofilament debridement pad for use in acute or chronic wounds (HTG334)

    Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds.

    HealthTech guidance
    Last updated
    25 March 2019
    View recommendations

    Sections for HTG334

  6. Diabetic foot ulcers - new treatments [ID381]

    Discontinued Reference number: GID-TAG371

    Technology appraisal guidance
    Discontinued

  7. WoundExpress to manage lower leg wounds (MIB261)

    NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds .

    Medtech innovation briefing
    Published
    1 June 2021

  8. When and with what criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?

    criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?...

    Research recommendation
    Published
    15 November 2019

  9. When and with what criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?

    criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?...

    Research recommendation
    Published
    15 November 2019

  10. What is the effectiveness of different footwear, insoles and orthoses in the prevention of foot problems?

    prevention of foot problems? Any explanatory notes(if applicable) Source guidance details Comes from guidance Diabetic foot...

    Research recommendation
    Published
    15 November 2019

  11. Within the hospital multidisciplinary team, when is it appropriate and effective to refer people with diabetes who have foot problems to specialist services such as investigative or interventional radiology, orthopaedic or vascular services, specialist pain management and specialist orthotics?

    when is it appropriate and effective to refer people with diabetes who have foot problems to specialist services such as investigative...

    Research recommendation
    Published
    15 November 2019

  12. Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds (MIB11)

    NICE has developed a Medtech Innovation Briefing (MIB) on Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds

    Medtech innovation briefing
    Published
    19 November 2014

  13. What strategies may be useful in the prevention of Charcot arthropathy?

    applicable) Source guidance details Comes from guidance Diabetic foot problems: prevention and management Number NG19 Date

    Research recommendation
    Published
    15 November 2019

  14. When is it safe to stop contact casting in the treatment of acute Charcot arthropathy?

    applicable) Source guidance details Comes from guidance Diabetic foot problems: prevention and management Number NG19 Date

    Research recommendation
    Published
    18 November 2019

  15. Which risk stratification tools can be used to predict the likelihood of Charcot arthropathy?

    applicable) Source guidance details Comes from guidance Diabetic foot problems: prevention and management Number NG19 Date

    Research recommendation
    Published
    18 November 2019